Transdermal formulations
US9687528B2 · kind B2 · utility
2Cited by
0References
7Claims
0Family size
Inventor
Key dates
| Filing date | Mar 11, 2016 |
| Grant date | Jun 27, 2017 |
| Priority date | — |
| Expiry date | Mar 11, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q19/007
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to transdermal and moisturizing compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.